title: Quality of life and health economic assessments of age-related macular degeneration.
abstract: In this article, we review measures of patient-reported outcomes that can show whether a treatment for age-related macular degeneration also provides patient-perceived benefits. In addition, we look at health economic measurements currently being used to develop cost-effectiveness models for age-related macular degeneration.
authors.affiliation: Alcon Research, Ltd., Fort Worth, Texas 76134-2099, USA.
authors.forename: David
authors.initials: D
authors.lastname: Covert
authors.forename: Gilles
authors.initials: G
authors.lastname: Berdeaux
authors.forename: Jan
authors.initials: J
authors.lastname: Mitchell
authors.forename: Clare
authors.initials: C
authors.lastname: Bradley
authors.forename: Rod
authors.initials: R
authors.lastname: Barnes
mesh_terms: D001766:Blindness / Q000191:economics; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics*; D006801:Humans; D008268:Macular Degeneration / Q000191:economics*; D011788:Quality of Life; D015354:Vision, Low / Q000191:economics